OYST News and Press, Oyster Point Pharma Inc.

NEW YORK, NY / ACCESSWIRE / November 24, 2022 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: UserTesting, Inc. (NYSE: USER)'s...

NEW YORK, NY / ACCESSWIRE / November 22, 2022 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: IAA, Inc. (NYSE: IAA)'s sale t...

NEW YORK, NY / ACCESSWIRE / November 17, 2022 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Benefitfocus, Inc. (NASDAQ:BNFT)...

Oyster Point Pharma press release ( NASDAQ: OYST ): Q3 GAAP EPS of -$1.37 misses by $0.11 . Revenue of $5.59M (-68.8% Y/Y) misses by $8.72M . For further details see: Oyster Point Pharma GAAP EPS of -$1.37 misses by $0.11, revenue of $5.59M misses by $8.7...

TYRVAYA ® (Varenicline Solution) Nasal Spray Achieved Net Product Revenue of $5.6 Million in Q3 ’ 22 Approximately 34,000 TYRVAYA Prescriptions Filled During the Quarter, with Prescriptions Written by Approximately 6,100 Unique Eye Care Profes...

Summary Viatris’ business is holding up better than expected, despite FX headwinds. A new path to growth clears visibility for investors as the company targets to be the next ophthalmology leader. In addition, the portion of shareholder rewards through dividends and buy...

NEW YORK, NY / ACCESSWIRE / November 9, 2022 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Ritchie Bros. Auctioneers Incorpo...

MONSEY, New York, Nov. 07, 2022 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating whether the directors of Oyster Point Pharma, Inc. (Nasdaq: OYST) (“Oyster”) acted in the best interests of Oyster shareholders in approving the sale of Oyster to Viatr...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Viatris (NASDAQ: VTRS ) issued a press release today with a slew of good news. For one thing, Viatris is acquiring two different businesses . Also, these acquisitions are expected to greatly enhance the company’...

Updated to add latest share price moves Oyster Point Pharma ( NASDAQ: OYST ), a company focused on eye disorders, announced Monday that Viatris ( NASDAQ: VTRS ) agreed to acquire it for $11.00 per share in cash plus a contingent value right (CVR). After a b...